PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding PDS Biotechnology Corp changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 52 | 1 | 48 | −3 |
| Shares | 4.25M | 2.00K | 8.24M | +3.99M (+93.8%) |
| Value | $6.94M | $3.26K | $9.81M | +$2.87M (+41.4%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held PDS Biotechnology Corp at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 4,419,000 | $5.26M | 0.14% |
| Amussen Hunsaker Associates LLC | 75,016 | $89.3K | 0.01% |
| JustInvest LLC | 28,523 | $33.9K | 0.00% |
| Ritholtz Wealth Management | 19,659 | $23.4K | 0.00% |
| First Manhattan Co | 15,000 | $17.9K | 0.00% |
| Sandbox Financial Partners, LLC | 12,666 | $15.1K | 0.01% |
| Hughes Financial Services, LLC | 764 | $825 | 0.00% |
| Rise Advisors, LLC | 325 | $387 | 0.00% |
| Northwestern Mutual Wealth Management Co | 257 | $306 | 0.00% |
Sold out (12)
Institutions that held PDS Biotechnology Corp at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 220,215 | $358.9K |
| Renaissance Technologies LLC | 100,000 | $163.0K |
| Two Sigma Investments, LP | 65,732 | $107.1K |
| Virtu Financial LLC | 54,693 | $89.0K |
| Vontobel Holding Ltd. | 40,000 | $65.2K |
| Marshall Wace, LLP | 39,024 | $63.6K |
| Jane Street Group, LLC | 35,644 | $58.1K |
| XTX Topco Ltd | 24,535 | $40.0K |
| Sherbrooke Park Advisers LLC | 14,026 | $22.9K |
| EverSource Wealth Advisors, LLC | 431 | $703 |
| R Squared Ltd | 300 | $489 |
| Citigroup Inc | 20 | $33 |
Not filed for Q1 2025 yet (1)
Institutions that held PDS Biotechnology Corp at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| WR Wealth Planners, LLC | 2,000 | $3.26K |